Shanghai Pharmaceuticals Holding Co., Ltd

SHSE:601607 Stok Raporu

Piyasa değeri: CN¥64.7b

Shanghai Pharmaceuticals Holding Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Shanghai Pharmaceuticals Holding şirketinin kazançları yıllık ortalama -0.01% oranında azalırken, Healthcare sektörünün kazançları yıllık 2% oranında artan oldu. Gelirler yıllık ortalama 8.9% oranında artan oldu. Shanghai Pharmaceuticals Holding şirketinin öz sermaye getirisi 6.3% olup, net marjı 1.5% dir.

Anahtar bilgiler

-0.006%

Kazanç büyüme oranı

-6.6%

EPS büyüme oranı

Healthcare Sektör Büyümesi7.0%
Gelir büyüme oranı8.9%
Özkaynak getirisi6.3%
Net Marj1.5%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Not Many Are Piling Into Shanghai Pharmaceuticals Holding Co., Ltd (SHSE:601607) Just Yet

Sep 30
Not Many Are Piling Into Shanghai Pharmaceuticals Holding Co., Ltd (SHSE:601607) Just Yet

Shanghai Pharmaceuticals Holding (SHSE:601607) Has Some Way To Go To Become A Multi-Bagger

Aug 09
Shanghai Pharmaceuticals Holding (SHSE:601607) Has Some Way To Go To Become A Multi-Bagger

Shanghai Pharmaceuticals Holding's (SHSE:601607) Dividend Is Being Reduced To CN¥0.41

Jul 18
Shanghai Pharmaceuticals Holding's (SHSE:601607) Dividend Is Being Reduced To CN¥0.41

Shanghai Pharmaceuticals Holding (SHSE:601607) Has A Somewhat Strained Balance Sheet

Jun 25
Shanghai Pharmaceuticals Holding (SHSE:601607) Has A Somewhat Strained Balance Sheet

Shanghai Pharmaceuticals Holding Co., Ltd's (SHSE:601607) Earnings Are Not Doing Enough For Some Investors

May 21
Shanghai Pharmaceuticals Holding Co., Ltd's (SHSE:601607) Earnings Are Not Doing Enough For Some Investors

Earnings Miss: Shanghai Pharmaceuticals Holding Co., Ltd Missed EPS By 30% And Analysts Are Revising Their Forecasts

Apr 01
Earnings Miss: Shanghai Pharmaceuticals Holding Co., Ltd Missed EPS By 30% And Analysts Are Revising Their Forecasts

Returns At Shanghai Pharmaceuticals Holding (SHSE:601607) Appear To Be Weighed Down

Mar 16
Returns At Shanghai Pharmaceuticals Holding (SHSE:601607) Appear To Be Weighed Down

We Think Shanghai Pharmaceuticals Holding (SHSE:601607) Can Stay On Top Of Its Debt

Feb 29
We Think Shanghai Pharmaceuticals Holding (SHSE:601607) Can Stay On Top Of Its Debt

Gelir ve Gider Dağılımı

Shanghai Pharmaceuticals Holding nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SHSE:601607 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 24272,4164,02518,4302,352
30 Jun 24267,1164,10018,6962,283
31 Mar 24264,2213,79319,3622,165
31 Dec 23260,2953,76819,7682,204
30 Sep 23254,8784,60020,0602,191
30 Jun 23252,8664,53120,9062,329
31 Mar 23241,3105,88420,2292,205
31 Dec 22231,9815,61719,4472,112
30 Sep 22229,4635,42318,5872,010
30 Jun 22222,2945,22118,8021,917
31 Mar 22221,1224,22418,4032,020
31 Dec 21215,8245,09318,3211,987
30 Sep 21212,5595,37817,6911,983
30 Jun 21209,9825,62117,0821,860
31 Mar 21203,0615,57817,0331,730
31 Dec 20191,9094,49616,7121,657
30 Sep 20186,2714,28417,2501,530
30 Jun 20181,1564,23717,1151,462
31 Mar 20181,0073,99317,2741,420
31 Dec 19186,5664,08117,6101,350
30 Sep 19182,1003,90817,6281,165
30 Jun 19175,7814,13416,9921,146
31 Mar 19168,7053,98716,0151,118
31 Dec 18159,0843,88115,0981,061
30 Sep 18149,4174,20413,8921,043
30 Jun 18140,9473,62912,607896
31 Mar 18134,1043,54111,5111,004
31 Dec 17130,8473,52110,601790
30 Sep 17129,2793,42810,436503
30 Jun 17126,8483,38910,230373
31 Mar 17124,6193,30610,2840
31 Dec 16120,7653,1969,9300
30 Sep 16116,9933,1559,4440
30 Jun 16114,2623,0759,2260
31 Mar 16109,6673,0338,7960
31 Dec 15105,5172,8778,5430
30 Sep 15102,7232,8578,5090
30 Jun 1599,3362,8078,2790
31 Mar 1596,2502,7388,1500
31 Dec 1492,3992,5917,8720
30 Sep 1488,8812,4777,5280
30 Jun 1483,5182,3717,2830
31 Mar 1479,9072,1747,1330
31 Dec 1378,2232,2147,1030

Kaliteli Kazançlar: 601607 yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: 601607 'nin mevcut net kar marjları (1.5%) geçen yılın (1.8%) değerinden daha düşüktür.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 601607 şirketinin kazançları son 5 yılda yılda 0.01% oranında azaldı.

Büyüme Hızlandırma: 601607 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: 601607 geçtiğimiz yıl negatif kazanç büyümesine ( -12.5% ) sahipti ve bu da onu Healthcare sektör ortalamasıyla ( -5.7% ) karşılaştırmayı zorlaştırıyordu.


Özkaynak Getirisi

Yüksek ROE: 601607 'nin Özsermaye Getirisi ( 6.3% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin